tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
RatingsAurinia Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
4d ago
AUPH
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Future Justify Buy Rating
PremiumRatings
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Future Justify Buy Rating
6d ago
AUPH
Aurinia Pharmaceuticals’ Earnings Call: Strong Growth and Optimism
PremiumCompany Announcements
Aurinia Pharmaceuticals’ Earnings Call: Strong Growth and Optimism
7d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Revenue Growth
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Revenue Growth
8d ago
AUPH
Optimistic Buy Rating for Lupkynis Driven by Strong Sales and Promising Clinical Developments
PremiumRatings
Optimistic Buy Rating for Lupkynis Driven by Strong Sales and Promising Clinical Developments
8d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Revenue Growth and Expands Share Repurchase Plan
PremiumCompany AnnouncementsAurinia Pharmaceuticals Reports Strong Revenue Growth and Expands Share Repurchase Plan
8d ago
AUPH
Aurinia Pharmaceuticals raises 2025 revenue view to $260M-$270M from $250M-$260M
Premium
The Fly
Aurinia Pharmaceuticals raises 2025 revenue view to $260M-$270M from $250M-$260M
8d ago
AUPH
Aurinia Pharmaceuticals reports Q2 EPS 16c, consensus 15c
Premium
The Fly
Aurinia Pharmaceuticals reports Q2 EPS 16c, consensus 15c
8d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q2 2025 Financial Results and Expands Share Repurchase Plan
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Q2 2025 Financial Results and Expands Share Repurchase Plan
8d ago
AUPH
Aurinia Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Aurinia Pharmaceuticals assumed with a Buy at H.C. Wainwright
9d ago
AUPH
Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results
PremiumCompany Announcements
Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results
17d ago
AUPH
Aurinia Pharmaceuticals Reports Positive Phase 1 Results for Aritinercept
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Positive Phase 1 Results for Aritinercept
1M ago
AUPH
Aurinia Pharma reports ‘positive’ results from Phase 1 study of aritinercept
PremiumThe FlyAurinia Pharma reports ‘positive’ results from Phase 1 study of aritinercept
1M ago
AUPH
Aurinia Pharmaceuticals to Discuss AUR200 Phase 1 Study Results
Premium
Company Announcements
Aurinia Pharmaceuticals to Discuss AUR200 Phase 1 Study Results
1M ago
AUPH
Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study
Premium
Company Announcements
Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study
3M ago
AUPH
Aurinia Pharmaceuticals’ Lupkinis therapy shows efficacy in lupus nephritis
PremiumThe Fly
Aurinia Pharmaceuticals’ Lupkinis therapy shows efficacy in lupus nephritis
3M ago
AUPH
Aurinia Pharmaceuticals Approves New Equity Incentive Plan
PremiumCompany Announcements
Aurinia Pharmaceuticals Approves New Equity Incentive Plan
3M ago
8K
AUPH
Aurinia Pharmaceuticals: Strong Buy Rating Backed by Robust Financials and Promising Pipeline
PremiumRatings
Aurinia Pharmaceuticals: Strong Buy Rating Backed by Robust Financials and Promising Pipeline
3M ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings
3M ago
AUPH
Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges
PremiumCompany AnnouncementsAurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges
3M ago
AUPH
Aurinia Pharmaceuticals: Promising Growth and Stability with Lupkynis and Pipeline Advancements
Premium
Ratings
Aurinia Pharmaceuticals: Promising Growth and Stability with Lupkynis and Pipeline Advancements
3M ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook
Premium
Company Announcements
Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook
3M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >